Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant.

Rohn H, Michita RT, Schramm S, Dolff S, Gäckler A, Korth J, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V.

Cells. 2019 Aug 7;8(8). pii: E847. doi: 10.3390/cells8080847.

2.

Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer.

Schwich E, Rebmann V, Horn PA, Celik AA, Bade-Döding C, Kimmig R, Kasimir-Bauer S, Buderath P.

Cancers (Basel). 2019 Aug 2;11(8). pii: E1106. doi: 10.3390/cancers11081106.

3.

Comparison of six commercial serum exosome isolation methods suitable for clinical laboratories. Effect in cytokine analysis.

Macías M, Rebmann V, Mateos B, Varo N, Perez-Gracia JL, Alegre E, González Á.

Clin Chem Lab Med. 2019 Sep 25;57(10):1539-1545. doi: 10.1515/cclm-2018-1297.

PMID:
30990781
4.

Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness.

Kordelas L, Schwich E, Dittrich R, Horn PA, Beelen DW, Börger V, Giebel B, Rebmann V.

Int J Mol Sci. 2019 Apr 2;20(7). pii: E1642. doi: 10.3390/ijms20071642.

5.

HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.

Schwich E, Rebmann V, Michita RT, Rohn H, Voncken JW, Horn PA, Kimmig R, Kasimir-Bauer S, Buderath P.

Sci Rep. 2019 Apr 1;9(1):5407. doi: 10.1038/s41598-019-41900-z.

6.

Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales.

Ludwig AK, De Miroschedji K, Doeppner TR, Börger V, Ruesing J, Rebmann V, Durst S, Jansen S, Bremer M, Behrmann E, Singer BB, Jastrow H, Kuhlmann JD, El Magraoui F, Meyer HE, Hermann DM, Opalka B, Raunser S, Epple M, Horn PA, Giebel B.

J Extracell Vesicles. 2018 Oct 17;7(1):1528109. doi: 10.1080/20013078.2018.1528109. eCollection 2018.

7.

A Valine Mismatch at Position 129 of MICA Is an Independent Predictor of Cytomegalovirus Infection and Acute Kidney Rejection in Simultaneous Pancreas⁻Kidney Transplantation Recipients.

Michita RT, Chies JAB, Schramm S, Horn PA, Heinemann FM, Wunsch A, Viebahn R, Schenker P, Rebmann V.

Int J Mol Sci. 2018 Sep 4;19(9). pii: E2618. doi: 10.3390/ijms19092618.

8.

The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.

Rohn H, Tomoya Michita R, Schwich E, Dolff S, Gäckler A, Trilling M, Le-Trilling VTK, Wilde B, Korth J, Heinemann FM, Horn PA, Kribben A, Witzke O, Rebmann V.

Front Immunol. 2018 May 8;9:917. doi: 10.3389/fimmu.2018.00917. eCollection 2018.

9.

The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer.

Schwich E, Rebmann V.

Front Immunol. 2018 Mar 26;9:584. doi: 10.3389/fimmu.2018.00584. eCollection 2018. Review.

10.

Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.

Kordelas L, da Silva Nardi F, Wagner B, Ditschkowski M, Liebregts T, Lindemann M, Heinemann FM, Horn PA, Beelen DW, Rebmann V.

Bone Marrow Transplant. 2018 Sep;53(9):1149-1156. doi: 10.1038/s41409-018-0145-1. Epub 2018 Mar 14.

PMID:
29540850
11.

Expansion of functional personalized cells with specific transgene combinations.

Lipps C, Klein F, Wahlicht T, Seiffert V, Butueva M, Zauers J, Truschel T, Luckner M, Köster M, MacLeod R, Pezoldt J, Hühn J, Yuan Q, Müller PP, Kempf H, Zweigerdt R, Dittrich-Breiholz O, Pufe T, Beckmann R, Drescher W, Riancho J, Sañudo C, Korff T, Opalka B, Rebmann V, Göthert JR, Alves PM, Ott M, Schucht R, Hauser H, Wirth D, May T.

Nat Commun. 2018 Mar 8;9(1):994. doi: 10.1038/s41467-018-03408-4.

12.

Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.

Babay W, Ben Yahia H, Boujelbene N, Zidi N, Laaribi AB, Kacem D, Ben Ghorbel R, Boudabous A, Ouzari HI, Rizzo R, Rebmann V, Mrad K, Zidi I.

Hum Immunol. 2018 Jun;79(6):463-470. doi: 10.1016/j.humimm.2018.02.012. Epub 2018 Mar 2.

PMID:
29499226
13.

Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy.

König L, Kasimir-Bauer S, Bittner AK, Hoffmann O, Wagner B, Santos Manvailer LF, Kimmig R, Horn PA, Rebmann V.

Oncoimmunology. 2017 Sep 27;7(1):e1376153. doi: 10.1080/2162402X.2017.1376153. eCollection 2017.

14.

Susceptibility of HLA-E*01:03 Allele Carriers to Develop Cytomegalovirus Replication After Living-Donor Kidney Transplantation.

Guberina H, da Silva Nardi F, Michita RT, Dolff S, Bienholz A, Heinemann FM, Wilde B, Trilling M, Horn PA, Kribben A, Witzke O, Rebmann V.

J Infect Dis. 2018 May 25;217(12):1918-1922. doi: 10.1093/infdis/jix638.

PMID:
29228302
15.

Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation.

Guberina H, Tomoya Michita R, Dolff S, Bienholz A, Trilling M, Heinemann FM, Horn PA, Kribben A, Witzke O, Rebmann V.

Int J Mol Sci. 2017 Nov 5;18(11). pii: E2338. doi: 10.3390/ijms18112338.

16.

Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival.

Guberina H, Rebmann V, Wagner B, da Silva Nardi F, Dziallas P, Dolff S, Bienholz A, Wohlschlaeger J, Bankfalvi A, Heinemann FM, Witzke O, Zoet YM, Claas FH, Horn PA, Kribben A, Doxiadis II.

Immunobiology. 2017 Mar;222(3):536-543. doi: 10.1016/j.imbio.2016.10.021. Epub 2016 Nov 4.

PMID:
27871782
17.

HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia.

Wagner B, da Silva Nardi F, Schramm S, Kraemer T, Celik AA, Dürig J, Horn PA, Dührsen U, Nückel H, Rebmann V.

Cancer. 2017 Mar 1;123(5):814-823. doi: 10.1002/cncr.30427. Epub 2016 Nov 2.

18.
19.

The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology.

Rebmann V, König L, Nardi Fda S, Wagner B, Manvailer LF, Horn PA.

Front Immunol. 2016 May 4;7:173. doi: 10.3389/fimmu.2016.00173. eCollection 2016.

20.

Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.

Crivello P, Heinold A, Rebmann V, Ottinger HD, Horn PA, Beelen DW, Fleischhauer K.

Blood. 2016 Jul 7;128(1):120-9. doi: 10.1182/blood-2015-12-686238. Epub 2016 May 9. Erratum in: Blood. 2016 Dec 8;128(23 ):2744.

Supplemental Content

Loading ...
Support Center